These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 25818291

  • 1. Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.
    Mak P, Li J, Samanta S, Chang C, Jerry DJ, Davis RJ, Leav I, Mercurio AM.
    Cell Rep; 2015 Mar 31; 10(12):1982-91. PubMed ID: 25818291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C, Ci X, Sun X, Fu X, Zhang Z, Dong EN, Hao ZZ, Dong JT.
    Neoplasia; 2014 Nov 31; 16(11):883-99. PubMed ID: 25425963
    [Abstract] [Full Text] [Related]

  • 4. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
    Mi J, Hooker E, Balog S, Zeng H, Johnson DT, He Y, Yu EJ, Wu H, Le V, Lee DH, Aldahl J, Gonzalgo ML, Sun Z.
    J Biol Chem; 2018 Dec 28; 293(52):20123-20136. PubMed ID: 30401749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene.
    Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, Sotgia F, Lisanti MP, Andò S, Aquila S.
    Cell Cycle; 2012 Aug 01; 11(15):2911-21. PubMed ID: 22810004
    [Abstract] [Full Text] [Related]

  • 9. Additive Effect of Zfhx3/Atbf1 and Pten Deletion on Mouse Prostatic Tumorigenesis.
    Sun X, Xing C, Fu X, Li J, Zhang B, Frierson HF, Dong JT.
    J Genet Genomics; 2015 Jul 20; 42(7):373-82. PubMed ID: 26233892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.
    Whelan JT, Kellogg A, Shewchuk BM, Hewan-Lowe K, Bertrand FE.
    J Cell Biochem; 2009 Aug 01; 107(5):992-1001. PubMed ID: 19479935
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z, He B, He J, Mao X.
    Prostate; 2013 May 01; 73(6):596-604. PubMed ID: 23060044
    [Abstract] [Full Text] [Related]

  • 13. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
    Ci X, Xing C, Zhang B, Zhang Z, Ni JJ, Zhou W, Dong JT.
    Mol Cancer; 2015 Apr 21; 14():91. PubMed ID: 25896712
    [Abstract] [Full Text] [Related]

  • 14. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
    Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP.
    Nature; 2005 Aug 04; 436(7051):725-30. PubMed ID: 16079851
    [Abstract] [Full Text] [Related]

  • 15. Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.
    Bado I, Nikolos F, Rajapaksa G, Wu W, Castaneda J, Krishnamurthy S, Webb P, Gustafsson JÅ, Thomas C.
    Breast Cancer Res; 2017 Jul 03; 19(1):79. PubMed ID: 28673316
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T, Remberger K, Bonkhoff H.
    Prostate; 2003 Feb 01; 54(2):79-87. PubMed ID: 12497580
    [Abstract] [Full Text] [Related]

  • 17. SENP1 regulates PTEN stability to dictate prostate cancer development.
    Bawa-Khalfe T, Yang FM, Ritho J, Lin HK, Cheng J, Yeh ET.
    Oncotarget; 2017 Mar 14; 8(11):17651-17664. PubMed ID: 27852060
    [Abstract] [Full Text] [Related]

  • 18. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
    Fan X, Bjerke GA, Riemondy K, Wang L, Yi R.
    Mol Carcinog; 2019 Dec 14; 58(12):2241-2253. PubMed ID: 31512783
    [Abstract] [Full Text] [Related]

  • 19. Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.
    Yun H, Xie J, Olumi AF, Ghosh R, Kumar AP.
    Oncotarget; 2015 May 10; 6(13):11600-13. PubMed ID: 25816367
    [Abstract] [Full Text] [Related]

  • 20. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
    Jiao J, Wang S, Qiao R, Vivanco I, Watson PA, Sawyers CL, Wu H.
    Cancer Res; 2007 Jul 01; 67(13):6083-91. PubMed ID: 17616663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.